# Kalaris Therapeutics, Inc.: Form DEF 14A, filed Apr 23, 2024

- Company: [Kalaris Therapeutics, Inc.](/companies/klrs.md) (CIK 1754068)
- Form: DEF 14A
- Filed: 2024-04-23
- Accepted by EDGAR: Apr 23, 2024, 16:05 ET
- Period: 2024-06-06
- Accession: 0001193125-24-106976
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1754068/000119312524106976/d621337ddef14a.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1754068/000119312524106976/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1754068/000119312524106976/d621337ddef14a.htm

Filed Apr 23, 2024.
Source: SEC EDGAR, the filing index for accession 0001193125-24-106976. Last ingested by Listed: Oct 26, 2026, 17:31 ET. No prices; not investment advice.